 |
Biosimilar drugs could save up to $110bn by 2020Lower-cost copies of complex biotech drugs, known as biosimilars, could save the US and Europe's five top markets as much as €98 billion ($110 billion) by 2020, a new analysis showed on Tuesday. Realising those savings, h More… |
|
Biosimilar drugs could save up to $110bn by 2020Lower-cost copies of complex biotech drugs, known as biosimilars, could save the US and Europe's five top markets as much as €98 billion ($110 billion) by 2020, a new analysis showed on Tuesday. Realising those savings, h More… |
 |
UAE’s biotechnology industry challenges in focusDuBiotech, the biotechnology and research Park dedicated to facilitating and fostering growth of the UAE’s life sciences, conducted an event focused on the challenges of stimulating the biotechnology industry in the UAE. Bio More… |
|
UAE’s biotechnology industry challenges in focusDuBiotech, the biotechnology and research Park dedicated to facilitating and fostering growth of the UAE’s life sciences, conducted an event focused on the challenges of stimulating the biotechnology industry in the UAE. Bio More… |
 |
Drug regulators face challenge of ‘biosimilars’Middle East drug regulators face a new challenge in dealing with a wave of "biosimilar" versions of established therapies. Some of the world's biggest-selling pharmaceuticals were developed in the first phase of the biotechnology revolutio More… |
